We are closer than ever to developing an urgently needed hepatitis C vaccine. But in order to get there we need your help.
Consider opportunities to partner with us in translating research into tangible commercial outcomes.
In collaboration with commercial partners we develop its intellectual property (IP) and over many years have developed a number of applications that are now in use around the world.
Our team supports our scientists in sourcing investment in (and protecting) their IP that allows their work to progress to the next level.
For public health researchers, the support offered by the team might result in diversified funding sources and/or international collaborators that extend the reach of their projects/studies.